Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation

The present invention provides a class of chemical compounds useful as efficacious drugs in the treatment of sickle cell disease and diseases characterized by unwanted or abnormal cell proliferation. The active compounds are substituted triaryl methane compounds or analogues thereof where one or mor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HAIDAR, REEM M, CLIFFORD, JOHN J, GAO, YING-DUO, BRUGNARA, CARLO, KHER, FALGUNI M, SACHDEVA, YESH P, BELLOT, JR., EMILE M, TAFT, HEATHER N, LOMBARDY, RICHARD JOHN, HALPERIN, JOSE, SUN, MINGHUA, FROIMOWITZ, MARK, KELLEHER, EUGENE W, MOUSSA, ADEL M
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HAIDAR
REEM M
CLIFFORD
JOHN J
GAO
YING-DUO
BRUGNARA
CARLO
KHER
FALGUNI M
SACHDEVA
YESH P
BELLOT, JR.
EMILE M
TAFT
HEATHER N
LOMBARDY
RICHARD JOHN
HALPERIN
JOSE
SUN
MINGHUA
FROIMOWITZ
MARK
KELLEHER
EUGENE W
MOUSSA
ADEL M
description The present invention provides a class of chemical compounds useful as efficacious drugs in the treatment of sickle cell disease and diseases characterized by unwanted or abnormal cell proliferation. The active compounds are substituted triaryl methane compounds or analogues thereof where one or more of the aryl groups is replaced with a heteroaryl, cycloalkyl or heterocycloalkyl group and/or the tertiary carbon atom is replaced with a different atom such as Si, Ge, N or P. The compounds inhibit mammalian cell proliferation, inhibit the Gardos channel of erythrocytes, reduce sickle erythrocyte dehydration and/or delay the occurrence of erythrocyte sickling or deformation.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US6028103A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US6028103A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US6028103A3</originalsourceid><addsrcrecordid>eNqFjM1KA0EQhPfiIajPkH6BQH5AvIoYvJucQ2e2xh3snR66Z4X4QD6ns5h7DkUVxVe16H4PltguQiPqwBkUdCw65d6Jc9_Eop8TnOoAg0aaHHESimpzRdXAdUSu1Ipi-G4xaaZGegpf0g4hQn1ysGOGrtEpDGwcKiz9oKfzhfic1UaW_0kxlRRhPP89dHeRxfF49ftuuX87vL6vUPQELxyQUU_Hj6f19nmz3r3sbhN_xllX2A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation</title><source>esp@cenet</source><creator>HAIDAR; REEM M ; CLIFFORD; JOHN J ; GAO; YING-DUO ; BRUGNARA; CARLO ; KHER; FALGUNI M ; SACHDEVA; YESH P ; BELLOT, JR.; EMILE M ; TAFT; HEATHER N ; LOMBARDY; RICHARD JOHN ; HALPERIN; JOSE ; SUN; MINGHUA ; FROIMOWITZ; MARK ; KELLEHER; EUGENE W ; MOUSSA; ADEL M</creator><creatorcontrib>HAIDAR; REEM M ; CLIFFORD; JOHN J ; GAO; YING-DUO ; BRUGNARA; CARLO ; KHER; FALGUNI M ; SACHDEVA; YESH P ; BELLOT, JR.; EMILE M ; TAFT; HEATHER N ; LOMBARDY; RICHARD JOHN ; HALPERIN; JOSE ; SUN; MINGHUA ; FROIMOWITZ; MARK ; KELLEHER; EUGENE W ; MOUSSA; ADEL M</creatorcontrib><description>The present invention provides a class of chemical compounds useful as efficacious drugs in the treatment of sickle cell disease and diseases characterized by unwanted or abnormal cell proliferation. The active compounds are substituted triaryl methane compounds or analogues thereof where one or more of the aryl groups is replaced with a heteroaryl, cycloalkyl or heterocycloalkyl group and/or the tertiary carbon atom is replaced with a different atom such as Si, Ge, N or P. The compounds inhibit mammalian cell proliferation, inhibit the Gardos channel of erythrocytes, reduce sickle erythrocyte dehydration and/or delay the occurrence of erythrocyte sickling or deformation.</description><edition>7</edition><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2000</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20000222&amp;DB=EPODOC&amp;CC=US&amp;NR=6028103A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20000222&amp;DB=EPODOC&amp;CC=US&amp;NR=6028103A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HAIDAR; REEM M</creatorcontrib><creatorcontrib>CLIFFORD; JOHN J</creatorcontrib><creatorcontrib>GAO; YING-DUO</creatorcontrib><creatorcontrib>BRUGNARA; CARLO</creatorcontrib><creatorcontrib>KHER; FALGUNI M</creatorcontrib><creatorcontrib>SACHDEVA; YESH P</creatorcontrib><creatorcontrib>BELLOT, JR.; EMILE M</creatorcontrib><creatorcontrib>TAFT; HEATHER N</creatorcontrib><creatorcontrib>LOMBARDY; RICHARD JOHN</creatorcontrib><creatorcontrib>HALPERIN; JOSE</creatorcontrib><creatorcontrib>SUN; MINGHUA</creatorcontrib><creatorcontrib>FROIMOWITZ; MARK</creatorcontrib><creatorcontrib>KELLEHER; EUGENE W</creatorcontrib><creatorcontrib>MOUSSA; ADEL M</creatorcontrib><title>Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation</title><description>The present invention provides a class of chemical compounds useful as efficacious drugs in the treatment of sickle cell disease and diseases characterized by unwanted or abnormal cell proliferation. The active compounds are substituted triaryl methane compounds or analogues thereof where one or more of the aryl groups is replaced with a heteroaryl, cycloalkyl or heterocycloalkyl group and/or the tertiary carbon atom is replaced with a different atom such as Si, Ge, N or P. The compounds inhibit mammalian cell proliferation, inhibit the Gardos channel of erythrocytes, reduce sickle erythrocyte dehydration and/or delay the occurrence of erythrocyte sickling or deformation.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2000</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjM1KA0EQhPfiIajPkH6BQH5AvIoYvJucQ2e2xh3snR66Z4X4QD6ns5h7DkUVxVe16H4PltguQiPqwBkUdCw65d6Jc9_Eop8TnOoAg0aaHHESimpzRdXAdUSu1Ipi-G4xaaZGegpf0g4hQn1ysGOGrtEpDGwcKiz9oKfzhfic1UaW_0kxlRRhPP89dHeRxfF49ftuuX87vL6vUPQELxyQUU_Hj6f19nmz3r3sbhN_xllX2A</recordid><startdate>20000222</startdate><enddate>20000222</enddate><creator>HAIDAR; REEM M</creator><creator>CLIFFORD; JOHN J</creator><creator>GAO; YING-DUO</creator><creator>BRUGNARA; CARLO</creator><creator>KHER; FALGUNI M</creator><creator>SACHDEVA; YESH P</creator><creator>BELLOT, JR.; EMILE M</creator><creator>TAFT; HEATHER N</creator><creator>LOMBARDY; RICHARD JOHN</creator><creator>HALPERIN; JOSE</creator><creator>SUN; MINGHUA</creator><creator>FROIMOWITZ; MARK</creator><creator>KELLEHER; EUGENE W</creator><creator>MOUSSA; ADEL M</creator><scope>EVB</scope></search><sort><creationdate>20000222</creationdate><title>Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation</title><author>HAIDAR; REEM M ; CLIFFORD; JOHN J ; GAO; YING-DUO ; BRUGNARA; CARLO ; KHER; FALGUNI M ; SACHDEVA; YESH P ; BELLOT, JR.; EMILE M ; TAFT; HEATHER N ; LOMBARDY; RICHARD JOHN ; HALPERIN; JOSE ; SUN; MINGHUA ; FROIMOWITZ; MARK ; KELLEHER; EUGENE W ; MOUSSA; ADEL M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US6028103A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2000</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HAIDAR; REEM M</creatorcontrib><creatorcontrib>CLIFFORD; JOHN J</creatorcontrib><creatorcontrib>GAO; YING-DUO</creatorcontrib><creatorcontrib>BRUGNARA; CARLO</creatorcontrib><creatorcontrib>KHER; FALGUNI M</creatorcontrib><creatorcontrib>SACHDEVA; YESH P</creatorcontrib><creatorcontrib>BELLOT, JR.; EMILE M</creatorcontrib><creatorcontrib>TAFT; HEATHER N</creatorcontrib><creatorcontrib>LOMBARDY; RICHARD JOHN</creatorcontrib><creatorcontrib>HALPERIN; JOSE</creatorcontrib><creatorcontrib>SUN; MINGHUA</creatorcontrib><creatorcontrib>FROIMOWITZ; MARK</creatorcontrib><creatorcontrib>KELLEHER; EUGENE W</creatorcontrib><creatorcontrib>MOUSSA; ADEL M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HAIDAR; REEM M</au><au>CLIFFORD; JOHN J</au><au>GAO; YING-DUO</au><au>BRUGNARA; CARLO</au><au>KHER; FALGUNI M</au><au>SACHDEVA; YESH P</au><au>BELLOT, JR.; EMILE M</au><au>TAFT; HEATHER N</au><au>LOMBARDY; RICHARD JOHN</au><au>HALPERIN; JOSE</au><au>SUN; MINGHUA</au><au>FROIMOWITZ; MARK</au><au>KELLEHER; EUGENE W</au><au>MOUSSA; ADEL M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation</title><date>2000-02-22</date><risdate>2000</risdate><abstract>The present invention provides a class of chemical compounds useful as efficacious drugs in the treatment of sickle cell disease and diseases characterized by unwanted or abnormal cell proliferation. The active compounds are substituted triaryl methane compounds or analogues thereof where one or more of the aryl groups is replaced with a heteroaryl, cycloalkyl or heterocycloalkyl group and/or the tertiary carbon atom is replaced with a different atom such as Si, Ge, N or P. The compounds inhibit mammalian cell proliferation, inhibit the Gardos channel of erythrocytes, reduce sickle erythrocyte dehydration and/or delay the occurrence of erythrocyte sickling or deformation.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US6028103A
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T06%3A02%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HAIDAR;%20REEM%20M&rft.date=2000-02-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS6028103A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true